In the News
Ophthalmic Artery Angioplasty
First published report of Dr. Pedro Lylyk’s case series of ophthalmic artery angioplasty performed in the treatment of patients with AMD. This case series took place at the acclaimed ENERI medical institution in Buenos Aires, Argentina, one of the most advanced medical facilities in the world!
Updated Insight into the Hemodynamic Model of AMD
Ophthalmic experts are rethinking the hemodynamic model of Age Related Macular Degeneration (AMD). Dr. Philip J Rosenfeld and colleagues dive into this topic, providing a contemporary take on a decades old theory.
Martinos Center Blood Flow Study
Hemodynamics experts at the Martinos Center publish outcomes of the study conducted with OcuDyne, evaluating altered blood flow in patients with and without AMD.
COVID Impact
Research enrollment is once again halted in Melbourne, Australia due to the COVID-19 Delta variant as Australia returns to lock-down.
First Patient
First subject with profound vision loss due to AMD is treated in Melbourne, Australia with the use of OcuDyne’s OPTiC System in the hands of Ronil Chandra, MD and his team at Monash Health, as part of Phase I of the OC-1901 protocol.
First Study
Enrollment finally reopens in Melbourne, Australia for the OC-1901 study!
COVID Impact
Enrollment is halted in Melbourne, Australia due to the COVID-19 global pandemic as Australia goes into lock-down.
Australian Study Approved
Protocol OC-1901 obtains Human Research Ethics Committee (HREC) approval to proceed in Melbourne, Australia. Enrollment opens at Centre for Eye Research Australia and Monash Health, two world renowned research facilities!
Clinical study details and site contacts can be located here: OC-1901 Australia | ANZCTR Listing
- « Previous
- 1
- 2